Literature DB >> 11359967

Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis.

M Möllers1, S P Aries, D Drömann, B Mascher, J Braun, K Dalhoff.   

Abstract

BACKGROUND: Pulmonary sarcoidosis is characterised by a mononuclear alveolitis with a predominance of CD4+ T cells and macrophages. We determined the intracellular expression of interferon (IFN)gamma, interleukin (IL)-2, tumour necrosis factor (TNF)alpha, IL-4, IL-5 and IL-10 in CD4+ and CD8+, naive and memory lymphocytes from blood and bronchoalveolar lavage (BAL) fluid using three colour flow cytometry.
METHODS: Eighteen untreated patients with pulmonary sarcoidosis were evaluated and stratified according to whether they had acute or chronic disease.
RESULTS: Significantly more T cells expressed Th1 than Th2 type cytokines in both BAL fluid and peripheral blood samples, regardless of clinical presentation. Significantly greater proportions of T cells secreted Th1 type cytokines in BAL fluid than in peripheral blood. Th1 type cytokines were more frequently expressed by peripheral and alveolar T cells in acute disease than in chronic disease. There were no significant differences between CD4+ and CD8+ T cells. Concerning naive and memory lymphocytes, significantly higher CD45RO:CD45RA ratios were found in BAL fluid than in blood, and increased expression of Th2 type cytokines was found in peripheral compared with alveolar memory T cells.
CONCLUSIONS: Our data support the immunopathogenetic concept of Th1/Th2 imbalance and compartmentalisation in pulmonary sarcoidosis and suggest that the cytokine patterns change during the course of disease. Expression of Th2 type cytokines in memory lymphocytes is decreased in the alveolar compartment compared with peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359967      PMCID: PMC1746073          DOI: 10.1136/thorax.56.6.487

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

1.  Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease.

Authors:  W A Wallace; S E Howie
Journal:  J Pathol       Date:  1999-03       Impact factor: 7.996

2.  Detection of intracellular cytokines by flow cytometry.

Authors:  T Jung; U Schauer; C Heusser; C Neumann; C Rieger
Journal:  J Immunol Methods       Date:  1993-02-26       Impact factor: 2.303

3.  Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.

Authors:  E Neville; A N Walker; D G James
Journal:  Q J Med       Date:  1983

4.  CD8 alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features.

Authors:  C Agostini; L Trentin; R Zambello; P Bulian; F Siviero; M Masciarelli; G Festi; A Cipriani; G Semenzato
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

5.  Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia.

Authors:  C Walker; W Bauer; R K Braun; G Menz; P Braun; F Schwarz; T T Hansel; B Villiger
Journal:  Am J Respir Crit Care Med       Date:  1994-10       Impact factor: 21.405

6.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

7.  Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy.

Authors:  C Prior; P L Haslam
Journal:  Am Rev Respir Dis       Date:  1991-01

8.  Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis.

Authors:  J Müller-Quernheim; C Saltini; P Sondermeyer; R G Crystal
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

9.  Increased CD45RO expression on T lymphocytes in mediastinal lymph node and pulmonary lesions of patients with pulmonary sarcoidosis.

Authors:  S B Fazel; S E Howie; A S Krajewski; D Lamb
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

10.  Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung.

Authors:  C Saltini; M Kirby; B C Trapnell; N Tamura; R G Crystal
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  21 in total

1.  Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.

Authors:  C C Murphy; L Duncan; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

2.  Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis.

Authors:  Nicholas K Arger; Melissa Ho; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-04-17       Impact factor: 3.415

3.  Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.

Authors:  Stephen A Hines; Diana M Stone; Melissa T Hines; Debby C Alperin; Donald P Knowles; Linda K Norton; Mary J Hamilton; William C Davis; Travis C McGuire
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 4.  Molecular profiling in sarcoidosis.

Authors:  Nicholas K Arger; Brian O'Connor; Laura L Koth
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

Review 5.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

6.  M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Authors:  Stefan Prokop; Frank L Heppner; Hans H Goebel; Werner Stenzel
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 7.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

8.  The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.

Authors:  Karen C Patterson; Kyle Hogarth; Aliya N Husain; Anne I Sperling; Timothy B Niewold
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

9.  Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.

Authors:  T Kurumagawa; S Seki; H Kobayashi; Y Koike; S Kanoh; H Hiraide; K Motoyoshi
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways.

Authors:  U M Zissler; A M Chaker; R Effner; M Ulrich; F Guerth; G Piontek; K Dietz; M Regn; B Knapp; F J Theis; H Heine; K Suttner; C B Schmidt-Weber
Journal:  Mucosal Immunol       Date:  2015-11-18       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.